<\/p>\n
OR<\/span><\/strong>organized by the Hon. Dr. Domenico Scilipoti, who introduced and concluded the works, <\/span>took place in Rome <\/span>the conference on 24 May 2010 at Palazzo Marini <\/span>by title \u201cPharmaceutical industry and scientific information: an increasingly difficult relationship\u201d.<\/p>\n <\/em><\/font><\/span><\/p>\n <\/p>\n <\/p>\n <\/span><\/p>\n In the presence of a large delegation of ISF, the following spoke: dr. Gaetano Mazzucconi, Head of the Italian Doctors Union (SMI); dr. Carmelo Carnovale \u2013 National Secretary of SLF-Cobas; dr. Italo Pallone del <\/span>FEDERISF Study Centre; dr. Raffaele Panebianco, Regional President of Federisf Sicilia; Prof. Avv. Antonio Pileggi, Full Professor of Labor Law at the Tor Vergata University of Rome; dr. Patrizio Mond\u00ec, AIISF Delegate for the problems of the work of the ISF; dr. Giorgio Vitali, President of Inforquadri; dr. Ciro Aurigemma, Psychologist.<\/p>\n <\/font><\/span><\/p>\n <\/p>\n <\/p>\n <\/span><\/p>\n The honorable Scilipoti, who is a doctor even before being a deputy, underlined the importance of creating a Professional Register of Scientific Information on Drugs for a better guarantee of correct information from doctors and pharmacists, monitoring of any events adverse events as well as the protection of public health. <\/p>\n <\/font><\/span><\/p>\n <\/p>\n <\/p>\n <\/span><\/p>\n The conference denounced the attack by pharmaceutical companies on the top management of the Associations which, more than others, are fighting to bring scientific information activities on drugs back into line with the regulatory provisions. In fact, the dismissal of the National President of Federisf Lucio Golia, for justified objective reasons, appears clearly discriminatory and operated as a retaliatory response by companies to clumsily silence those who oppose commercial initiatives carried out to the detriment of public health and the NHS.<\/p>\n <\/font><\/span><\/p>\n <\/p>\n <\/p>\n <\/span><\/p>\n